Literature DB >> 13952731

Mechanism of action of fibrinolysin in the prevention of irreversible hemorrhagic shock.

R M HARDAWAY, J W BURNS.   

Abstract

Entities:  

Keywords:  FIBRINOLYSIN; SHOCK, HEMORRHAGIC

Mesh：

Substances：

Year:  1963        PMID： 13952731      PMCID： PMC1466438          DOI： 10.1097/00000658-196302000-00020

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  3 in total

1.  Role of norepinephrine in irreversible hemorrhagic shock.

Authors:  R M HARDAWAY; R E NEIMES; J W BURNS; H P MOCK; P T TRENCHAK
Journal:  Ann Surg       Date:  1962-07       Impact factor: 12.969

2.  The role of intravascular clotting in the etiology of shock.

Authors:  R M HARDAWAY
Journal:  Ann Surg       Date:  1962-03       Impact factor: 12.969

3.  Studies on the role of intravascular coagulation in irreversible hemorrhagic shock.

Authors:  R M HARDAWAY; W H BRUNE; E F GEEVER; J W BURNS; H P MOCK
Journal:  Ann Surg       Date:  1962-02       Impact factor: 12.969
  3 in total
  10 in total

1.  STUDIES ON THE FIBRINOGEN REPLACEMENT RATE IN DOGS.

Authors:  R M HARDAWAY; D G JOHNSON; M J ELOVITZ; D N HOUCHIN; E B JENKINS; J W BURNS; D R JACKSON
Journal:  Ann Surg       Date:  1964-11       Impact factor: 12.969

2.  Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?

Authors:  Hunter B Moore; Ernest E Moore; Michael P Chapman; Kirk C Hansen; Mitchell J Cohen; Frederic M Pieracci; James Chandler; Angela Sauaia
Journal:  J Am Coll Surg       Date:  2019-03-29       Impact factor: 6.113

3.  Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis.

Authors:  Hunter B Moore; Ernest E Moore; Benjamin R Huebner; Gregory R Stettler; Geoffrey R Nunns; Peter M Einersen; Christopher C Silliman; Angela Sauaia
Journal:  J Surg Res       Date:  2017-05-08       Impact factor: 2.192

4.  Coagulation disturbances in shock.

Authors:  H G Lasch
Journal:  Postgrad Med J       Date:  1969-08       Impact factor: 2.401

5.  [Heparin therapy in hemorrhagic traumatic shock].

Authors:  S Popov; M Dohmen; H Egli
Journal:  Langenbecks Arch Chir       Date:  1969

6.  Bloodless surgery by means of profound hypothermia and circulatory arrest. Effect on brain and heart.

Authors:  J E Connolly; A Roy; J M Guernsey; E A Stemmer
Journal:  Ann Surg       Date:  1965-10       Impact factor: 12.969

7.  Refractory shock.

Authors:  R K Chandra
Journal:  Indian J Pediatr       Date:  1966-04       Impact factor: 1.967

Review 8.  A brief overview of acute respiratory distress syndrome.

Authors:  Robert M Hardaway
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

Review 9.  Is Coagulopathy an Appropriate Therapeutic Target During Critical Illness Such as Trauma or Sepsis?

Authors:  Hunter B Moore; Robert D Winfield; Mayuki Aibiki; Matthew D Neal
Journal:  Shock       Date:  2017-08       Impact factor: 3.454

10.  Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.

Authors:  Franklin L Wright; Thomas O Vogler; Ernest E Moore; Hunter B Moore; Max V Wohlauer; Shane Urban; Trevor L Nydam; Peter K Moore; Robert C McIntyre
Journal:  J Am Coll Surg       Date:  2020-05-15       Impact factor: 6.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.